CleanSpace Holdings Ltd. AI Stock Analysis
Want to see AU:CSX full AI Analyst Report?
CleanSpace Holdings Ltd. (CSX) AI Stock Analysis
CleanSpace Holdings Ltd.
(ASX:CSX)
CleanSpace scores below average, driven primarily by weak financial performance: flat revenue near $19.8M, a sharp fall in reported gross margin, a widening net loss of $1.2M, and free cash flow slipping back into negative territory. The key strength is a conservative, largely equity-funded balance sheet with minimal debt (debt-to-equity of roughly 0.08), which limits solvency risk and buys time for the turnaround, though ongoing losses continue to erode the equity base. Technicals provide modest support as the price has reclaimed its short-term moving averages with a positive MACD, but the stock still trades below its 200-day average and momentum indicators are stretched. Valuation adds little, with negative earnings and no dividend. Score would improve on evidence of renewed revenue growth, margin recovery and sustained positive free cash flow.
CleanSpace Holdings Ltd. (CSX) vs. iShares MSCI Australia ETF (EWA)
- Market Cap
- AUD 39.38M
- Dividend Yield
- ―
- Average Volume (3M)
- 42.63K
- Price to Earnings (P/E)
- -31.2
- Beta (1Y)
- 0.58
- Revenue Growth
- 0.29%
- EPS Growth
- -148.39%
- Country
- Australia
- Employees
- 53
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Devices
CleanSpace Holdings Ltd. Business Overview & Revenue Model
Company Description
CleanSpace Holdings Limited is a global enterprise focused on the design, manufacturing, and sale of personal respiratory protective equipment and related services. The company's advanced solutions serve healthcare professionals and a wide array of i...
How the Company Makes Money
CleanSpace generates revenue primarily from the sale of its respiratory protection products. Key revenue streams typically include (1) hardware sales of its PAPR units and associated components, and (2) ongoing consumables and replacement items used...
CleanSpace Holdings Ltd. Financial Statement Overview
Summary
Financials are mixed but skew weak. The income statement (30) is the main drag: revenue has stalled at roughly $19.8M, reported gross margin collapsed from about 74.8% to 20.6%, and the company posted a wider operating loss of $2.4M and a net loss of $1.2M (-6.3% net margin) — a sixth straight year without consistent profitability. Cash flow (38) also stepped backwards, with operating cash flow falling from $1.1M to just $69K and free cash flow swinging to a small outflow of about $142K, so the business is not yet self-funding. The balance sheet (64) is the offset: debt was cut to about $1.4M for a very conservative debt-to-equity of roughly 0.08, and equity of $18.5M funds nearly 79% of assets, providing runway. However, equity has eroded from $40.7M in FY2021 to $18.5M and return on equity remains negative at about -6.7%.
Income Statement
30NegativeBalance Sheet
64PositiveCash Flow
38Negative| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.82M | 19.82M | 19.76M | 15.72M | 12.09M | 13.36M |
| Gross Profit | 3.64M | 4.07M | 14.78M | 11.36M | -5.16M | 9.75M |
| EBITDA | -1.37M | -1.60M | -359.84K | -3.49M | -10.55M | -14.10M |
| Net Income | -1.25M | -1.25M | -478.28K | -3.13M | -8.13M | -11.28M |
Balance Sheet | ||||||
| Total Assets | 23.46M | 23.46M | 27.57M | 26.05M | 28.98M | 38.36M |
| Cash, Cash Equivalents and Short-Term Investments | 10.08M | 10.08M | 10.47M | 9.76M | 12.16M | 24.30M |
| Total Debt | 1.45M | 1.45M | 4.54M | 3.45M | 4.00M | 4.13M |
| Total Liabilities | 4.96M | 4.96M | 8.41M | 6.95M | 7.02M | 8.60M |
| Stockholders Equity | 18.50M | 18.50M | 19.16M | 19.10M | 21.96M | 29.75M |
Cash Flow | ||||||
| Free Cash Flow | -141.85K | -141.86K | 1.01M | -1.76M | -11.97M | -13.60M |
| Operating Cash Flow | 69.20K | 69.20K | 1.11M | -1.73M | -11.96M | -13.00M |
| Investing Cash Flow | -622.07K | -622.07K | -778.38K | 2.00M | 7.06M | -628.00K |
| Financing Cash Flow | -254.56K | -254.56K | -559.87K | -637.10K | -211.49K | -357.95K |
CleanSpace Holdings Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CSX, the sentiment is Positive. The current price of 0.48 is above the 20-day moving average (MA) of 0.46, above the 50-day MA of 0.44, and above the 200-day MA of 0.44, indicating a bullish trend. The MACD of 0.01 indicates Negative momentum. The RSI at 57.56 is Neutral, neither overbought nor oversold. The STOCH value of 82.05 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:CSX.
CleanSpace Holdings Ltd. Peers Comparison
Overall Rating
AU:RMD84Outperform
AU:CMP54Neutral
AU:CYC47Neutral- AU:CSX47Neutral
AU:AT144Neutral
AU:MX138Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| AU:RMD | 84Outperform | AUD 49.76B | 21.80 | 25.14% | 1.03% | 1.54% | 4.43% |
| AU:CMP | 54Neutral | AUD 48.94M | 222.73 | 0.93% | ― | 18.54% | ― |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| AU:CYC | 47Neutral | AUD 57.84M | -2.88 | -62.14% | ― | 12.05% | -31.71% |
| AU:CSX | 47Neutral | AUD 38.10M | -31.17 | -6.27% | ― | 0.29% | -148.39% |
| AU:AT1 | 44Neutral | AUD 10.83M | -2.86 | -48.97% | ― | 40.65% | 45.45% |
| AU:MX1 | 38Underperform | AUD 22.59M | -2.10 | -188.06% | ― | 15.58% | 37.17% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AU:CSX | CleanSpace Holdings Ltd. | 0.48 | -0.23 | -32.39% | |
| AU:CMP | Compumedics Limited | 0.24 | -0.10 | -28.99% | |
| AU:AT1 | Atomo Diagnostics Ltd. | 0.01 | -0.02 | -60.00% | |
| AU:CYC | Cyclopharm Limited | 0.46 | -0.18 | -28.68% | |
| AU:MX1 | Micro-X Ltd. | 0.03 | -0.07 | -70.00% | |
| AU:RMD | Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh | 34.96 | -2.18 | -5.87% |
CleanSpace Holdings Ltd. Corporate Events
CleanSpace Holdings Reports Further On-Market Share Buyback
CleanSpace Holdings reported the on-market repurchase of 64,860 fully paid ordinary shares on November 5, bringing total buybacks under the program to 116,318 shares. The daily notification indicates the company continues executing its previously ann...
CleanSpace Sets 24 November 2026 AGM and Tables 2026 Annual Report
CleanSpace Holdings Limited has called its Annual General Meeting for 24 November 2026 at its St Leonards, New South Wales premises, with shareholders also able to follow proceedings via a live Microsoft Teams webcast. The company has released its 20...
CleanSpace Sets November AGM With Focus on Governance and Remuneration Vote
CleanSpace Holdings Limited has called its Annual General Meeting for 24 November 2026 at the company’s premises in St Leonards, New South Wales, with shareholders also able to follow proceedings via a non-voting livestream. The 2026 Annual Report, i...
CleanSpace Director Paul Cassano Lifts Equity Stake via On-Market Share Purchase
CleanSpace Holdings disclosed a change in director Paul Cassano’s shareholding, reflecting an on-market purchase of additional fully paid ordinary shares. The transaction increases Cassano’s direct stake in the company, and underscores ongoing inside...
CleanSpace Director Cassano Boosts Shareholding via On-Market Trades
CleanSpace Holdings Ltd., an Australia-listed provider of respiratory protection and workplace safety products, operates in industrial and healthcare markets where robust health and safety compliance is essential. The company’s shares are quoted on t...
CleanSpace Seeks ASX Quotation for Employee Scheme Shares
CleanSpace Holdings Ltd. has applied for quotation on the ASX of 16,933 ordinary fully paid shares, with an issue date of 1 September 2026. The securities were previously issued under an employee incentive scheme and are now becoming transferable, ma...
CleanSpace publishes FY26 results presentation with investor guidance and disclaimers
CleanSpace Holdings Ltd has released its FY26 results presentation for the year ended 30 June 2026, outlining financial information prepared in accordance with IFRS and supplemented by non-IFRS metrics such as EBITDA and free cash flow to clarify ope...
CleanSpace Confirms 2026 Corporate Governance Compliance Under ASX Rules
CleanSpace Holdings Ltd., an ASX-listed provider of industrial respiratory protection technology, has confirmed its corporate governance framework for the financial year ended 30 June 2026. The company operates under the ASX Corporate Governance Coun...
CleanSpace Posts Wider Loss Despite Stable Revenue in 2026
CleanSpace Holdings Limited has reported a modest 0.3% increase in revenue to $19.8 million for the year ended 30 June 2026, but a sharply wider net loss after tax of $1.25 million, up 160.8% from the prior year. Basic and diluted earnings per share...
CleanSpace Launches 10% On-Market Share Buyback to Signal Confidence in Growth
CleanSpace Holdings Ltd., an Australian maker of premium respiratory protection solutions for industrial and healthcare users, builds on two decades of technology-driven advances in protective equipment. Backed by biomedical engineering expertise, th...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 08, 2026